Multiple Sclerosis Global Support Network News

"Your trusted source for the latest in MS news and information."

  • MS Info Hub
  • MS News

Multiple Sclerosis and the Self-Perception of Health

Multiple sclerosis (MS) is a disease of many and often diverse symptoms. Widely considered an autoimmune disorder, meaning that the immune system of an...

Pro-inflammatory Bacteria Found in MS Patients Why Researchers View the Microbiome...

The microbiome of people with multiple sclerosis (MS) has higher concentrations of bacteria types that promote inflammation and lower concentrations of at least one...

ECTRIMS 2017: T-cell vs. B-cell Debate More Meeting of Minds Than...

One particular session on Day 2 of the four-day 7th Joint ECTRIMS-ACTRIMS Meeting — which drew 10,000 researchers, doctors, industry representatives, and patient advocates to hear...

ECTRIMS 2017: Dr. Hafler From Yale Discusses B-Cells, Genetics, Promising Research,...

Dr. Hafler in many respects, is credited with identifying the central mechanisms underlying the likely cause of MS and is considered one of the...

ECTRIMS 2017: Bruce Cree, MD, PhD: Brain Volume Loss and Disability...

Bruce Cree, MD, PhD, an associate professor of clinical neurology at UCSF Medical School, spoke with MD Magazine at MS Paris 2017 about the...

ECTRIMS 2017: Multiple Sclerosis Lesion Location Linked to Hyperalgesia, Hypoalgesia

In patients with multiple sclerosis (MS), lesions in the right dorsolateral prefrontal cortex and posterior periventricular area may be associated with hypo and hyperalgesia, according...

ECTRIMS 2017: Promising Work in Pediatric and Secondary Progressive Patients Is...

Gilenya (fingolimod) lowered relapse rates in children and adolescents with relapsing multiple sclerosis at a “magnitude” — almost 82 percent — never before seen in...

Subscribe to Informatics BC Platforms System Seeks to Unravel Mysteries of...

CHICAGO (GenomeWeb) – In September, BC Platforms introduced BCRquest.com, a system for analyzing and viewing deidentified genomic and clinical data from multiple biobanks. The technology now...

ECTRIMS 2017: Early High-Efficacy Treatment Reduces Disability Accumulation in Young MS...

While early use of high-efficacy treatments lowers relapse rates among patients with relapsing-remitting multiple sclerosis (MS) compared to lower-efficacy ones, starting these therapies earlier...

ECTRIMS 2017: Quitting Smoking, Boosting Vitamin D Reduces MS Healthcare Costs,...

People with multiple sclerosis (MS) who quit smoking have better health outcomes than those who continue. Therefore, MS-related costs can be reduced by encouraging smokers...

Subscribe To Our Newsletter